a 2023

CYP2C19 and CYP3A4 activity is associated with survival in ticagrelor-treated patients after ST-elevation myocardial infarction

MÁCHAL, Jan, Ota HLINOMAZ, Katarína KOSTOLANSKÁ, Ondřej PEŠ, Zbyněk ŠPLÍCHAL et. al.

Basic information

Original name

CYP2C19 and CYP3A4 activity is associated with survival in ticagrelor-treated patients after ST-elevation myocardial infarction

Authors

MÁCHAL, Jan (203 Czech Republic, belonging to the institution), Ota HLINOMAZ (203 Czech Republic, belonging to the institution), Katarína KOSTOLANSKÁ (703 Slovakia, belonging to the institution), Ondřej PEŠ (203 Czech Republic, belonging to the institution), Zbyněk ŠPLÍCHAL (203 Czech Republic, belonging to the institution), Alena MÁCHALOVÁ (203 Czech Republic), Jonáš POKORNÝ (203 Czech Republic), Zuzana MOŤOVSKÁ (703 Slovakia) and Jan JUŘICA (203 Czech Republic)

Edition

91st European Atherosclerosis Society Congress, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Germany

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/23:00131611

Organization unit

Faculty of Medicine

DOI

Keywords in English

ST-elevation myocardial infarction

Tags

International impact, Reviewed
Změněno: 10/4/2024 07:54, Mgr. Tereza Miškechová

Abstract

V originále

CYP2C19 and CYP3A4 activity is associated with survival in ticagrelor-treated patients after ST-elevation myocardial infarction - conference abstract.

Links

GA16-06106S, research and development project
Name: Vysoce efektivní systém založený na kapilární elektroforéze pro screening inhibitorů beta-sekretázy jako terapeutického cíle pro Alzheimerovu chorobu (Acronym: Alzheimer)
Investor: Czech Science Foundation
MUNI/A/1063/2016, interní kód MU
Name: Experimentální a translační farmakologický výzkum a vývoj
Investor: Masaryk University, Category A